Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
Michael C d'Emden, Alicia J Jenkins, Liping Li, Diana Zannino, Kristy P Mann, James D Best, Bronwyn GA Stuckey, Kris Park, Juha Saltevo, Anthony C Keech
Diabetologia | SPRINGER | Published : 2014
Awarded by National Health and Medical Research Council of Australia
FIELD was supported by a grant from Laboratoires Fournier, Dijon, France (now part of Abbott Pharmaceuticals) and by the National Health and Medical Research Council of Australia (grants 457103, 1024105 and 1037786) and was coordinated independently by the NHMRC CTC.